CTRI/2024/08/072039
Not yet recruiting
Phase 3
Effect of timing of oxytocin administration in third stage of labor - nil
nil0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: O80- Encounter for full-term uncomplicated delivery
- Sponsor
- nil
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion Criteria
- •The following women undergoing vaginal birth will be eligible for enrollment in the study:
- •Gestation greater than 35 weeks of gestation
- •Singleton gestation
- •Last Hb during pregnancy more than 8\.0 gm/dl
Exclusion Criteria
- •Pregnant women with coagulopathy and bleeding disorder
- •Pregnant women with APH (Placenta previa, placental abruption, uterine rupture and vasa previa)
- •Fetal distress
- •Severe FGR (fetal growth retardation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
To study the effect of a drug used during caesarean section, on tightening of the uterus.Health Condition 1: O82- Encounter for cesarean delivery without indicationCTRI/2021/03/031925Jss Hospital90
Recruiting
Phase 4
Effect of timing of oxytocin administration during delayed cord clamping in term infantsACTRN12615001299594Monash Health192
Completed
Phase 4
se of oxytocin at different rates for contraction of uterus during caesarean delivery in patients in labourHealth Condition 1: null- Full term pregnant patients in labour undergoing caesarean sectionCTRI/2017/11/010496niversity College of Medical Sciences and GTB Hospital105
Completed
Phase 4
se of oxytocin at different rates for contraction of uterus during planned caesarean deliveryHealth Condition 1: null- Full term pregnant patients undergoing elective caesarean sectionCTRI/2017/11/010462niversity College of Medical Sciences and GTB Hospital120
Completed
Phase 2
Delivery of retained placenta .Condition 1: Retained placenta. Condition 2: Retained placenta. Condition 3: Retained placenta.Retained placenta without haemorrhageMorbidly adherent placentaSequelae of complication of pregnancy, childbirth and the puerperiumIRCT201405222624N16Vice chancellor for research ,Iran University of Medical Sciences.80